Home » About Us » Our Team » Philip Wong, Ph.D.

Philip Wong, Ph.D.

ADRC Associate Director
E-mail: [email protected]

Philip Wong is Professor of Pathology at Johns Hopkins University School of Medicine. His research program is focused on understanding the molecular mechanisms of neurodegenerative disorders, such as Alzheimer’s Disease and ALS. He uses transgenic animal models to study disease mechanisms and to design and test therapeutic strategies.


  • Kim D, Tu K, Wei A, Lau A, Gonzalez-Gil A, Cao T, Braunstein K, Ling J, Troncoso J, Wong P, Blackshaw S, Schnaar R, Li T. Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes. Mol Neurodegener, 2022; 17: 83.
  • Islam S, Sun Y, Gao Y, Nakamura T, Noorani A, Li T, Wong PC, Kimura N, Matsubara E, Kasuga K, Ikeuchi T, Tomita T, Zou K, Michikawa M. Presenilin is essential for ApoE secretion, a novel role of presenilin involved in Alzheimer’s disease pathogenesis. J Neursci, 2022; 42: 1574-1586
  • Jeong Y, Ling J, Lin S, Donde A, Braunstein K, Majounie E, Traynor B, LaClair K, Lloyd T, Wong PC. TDP-43 cryptic exons are highly variable among cell types. Mol Neurodegener 2017; 12: 13.
  • Sun M, Bell W, LaClair K, Ling J, Han H, Kageyama Y, Pletnikova O, Troncoso J, Wong PC, Chen LL. Cryptic exon incorporation occurs in Alzheimer’s brain lacking TDP-43 inclusion but exhibiting nuclear clearance of TDP-43. Acta Neuropathol 2017; 133: 923-931.
  • LaClair K, Donde A, Ling J, Jeong Y,Chhabra R, Martin L, Wong PC. Depletion of TDP-43 decreases fibril and plaque Beta amyloid and exacerbates neurodegeneration in an Alzheimer’s mouse model. Acta Neuropathol 2016; 132: 859-873.


Primary Appointment in Pathology